Jump to content
  • Sign Up
Sign in to follow this  

Dermocosmetic Treatment for ETR (Subtype 1)

Recommended Posts

A new dermocosmetic treatment done by some researchers at Induchem Companies, and Le CBM discovered some active ingredients to treat ETR, which is the most difficult rosacea subtype to treat.  

The dermocosmetic active ingredient is composed of three glucosylated derivatives of natural plants hydroxybenzoic acid and hydroxycinnamic acids (rosmarinic acid, gallic acid, and caffeic acid).  

The results of the study concluded, "the studies have shown that this active ingredient could be a dermocosmetic support, especially for erythematotelangiectatic rosacea armamentarium."

Clin Cosmet Investig Dermatol. 2015; 8: 501–510.
Published online 2015 Oct 1. doi:  10.2147/CCID.S92326
PMCID: PMC4598363
Combination of new multifunctional molecules for erythematotelangiectatic rosacea disorder
Hanane Chajra, [1] Mahdi Nadim, [2] Daniel Auriol,[3] Kuno Schweizer, [1] and Fabrice Lefèvre [1]
[1] Induchem AG, Volkestwil, Switzerland
[2] CBM-CNRS, Orléans Cedex, France
[3] Libragen SA, Toulouse, France

Share this post

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Sign in to follow this  

  • Create New...